SCHEMBL31552027

SCHEMBL31552027

[2H]C([2H])(Oc1nc(N2CCCC[C@H]3[C@H](F)[C@H]32)c2cnc(Cl)c(C)c2n1)[C@@]12CCCN1CC(=C)C2

nearest known ligand 0.37

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ KRAS P01116 20/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31551999 1.00 KRAS (0.37) KRAS
SCHEMBL31551737 0.80 KRAS (0.43) KRAS
SCHEMBL31552081 0.79 KRAS (0.48) KRAS
SCHEMBL31610039 0.79 KRAS (0.48) KRAS
SCHEMBL31552014 0.78 KRAS (0.47) KRAS
SCHEMBL31551990 0.76 KRAS (0.39) KRAS
SCHEMBL31552189 0.76 KRAS (0.47) KRAS
SCHEMBL31552238 0.76 KRAS (0.36) KRAS
SCHEMBL31552003 0.74 PDE2A (0.36) —
SCHEMBL31551769 0.73 PDE2A (0.30) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025064542-A1 KRAS MODULATORS ALTEROME THERAPEUTICS, INC. (US) 2025-03-27 — — WO disclosed
Send feedback